Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.40 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.40 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.35 |
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 0.35 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.35 |
| ▸ | USP7 | Q93009 | 2/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30619390 | 1.00 | MEN1 (0.44) | MEN1NPC1RAB9AKMT2AHSD17B1 | |
| SCHEMBL1585520 | 0.87 | NPC1 (0.50) | MEN1NPC1RAB9AKMT2AHSD17B1 | |
| SCHEMBL2325516 | 0.85 | LTA4H (0.47) | MEN1NPC1RAB9AKMT2AMAPT | |
| SCHEMBL19461191 | 0.85 | ALDH1A1 (0.56) | MEN1NPC1RAB9AKMT2APIK3CD | |
| SCHEMBL17795051 | 0.85 | EGLN1 (0.44) | MEN1NPC1RAB9AKMT2AMAPT | |
| SCHEMBL903918 | 0.83 | WNT3A (0.40) | MEN1NPC1RAB9AKMT2A | |
| SCHEMBL20448329 | 0.83 | MEN1 (0.39) | MEN1NPC1RAB9AKMT2AHSD17B1 | |
| SCHEMBL17809709 | 0.80 | EGLN1 (0.44) | MEN1NPC1RAB9AKMT2AMAPT | |
| SCHEMBL20646149 | 0.80 | MMP3 (0.57) | RIPK1MAP4K4 | |
| SCHEMBL31737439 | 0.80 | ALDH5A1 (0.46) | MEN1NPC1RAB9AKMT2AMKNK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10800717-B2 | Palladium-based supported hydrogenation catalyst, and preparation method and application thereof | PETROCHINA COMPANY LIMITED (CN) | 2020-10-13 | — | — | US | claimed |
| US-10800717-B2 | Palladium-based supported hydrogenation catalyst, and preparation method and application thereof | PETROCHINA COMPANY LIMITED (CN) | 2020-10-13 | — | — | US | disclosed |
| CN-105732265-B | Carbon two selective hydrogenation method in sequential separation process | 中国石油天然气股份有限公司 | 2019-07-05 | — | — | CN | disclosed |
| CN-105732269-B | Selective hydrogenation method for carbon two-fraction in sequential separation process | 中国石油天然气股份有限公司 | 2019-04-09 | — | — | CN | disclosed |
| CN-105732270-B | Front hydrogenation method for trace acetylene in methanol-to-olefin device | 中国石油天然气股份有限公司 | 2019-04-05 | — | — | CN | disclosed |
| CN-105727946-B | Preparation method of palladium-silver supported hydrogenation catalyst | 中国石油天然气股份有限公司 | 2019-02-15 | — | — | CN | disclosed |
| CN-105727990-B | Preparation method of palladium-copper supported hydrogenation catalyst | 中国石油天然气股份有限公司 | 2019-02-15 | — | — | CN | disclosed |
| CN-105749909-B | Preparation method of palladium-lead supported hydrogenation catalyst | 中国石油天然气股份有限公司 | 2019-01-18 | — | — | CN | disclosed |
| CN-105732272-B | Selective hydrogenation method for trace acetylene in methanol-to-olefin device | 中国石油天然气股份有限公司 | 2018-10-16 | — | — | CN | disclosed |
| CN-105749910-B | Palladium-lead supported hydrogenation catalyst | 中国石油天然气股份有限公司 | 2018-10-16 | — | — | CN | disclosed |
| CN-105732283-A | Method for selective hydrofining of ethylene | 中国石油天然气股份有限公司 | 2016-07-06 | — | — | CN | disclosed |
| CN-105732265-A | Carbon two selective hydrogenation method in sequential separation process | 中国石油天然气股份有限公司 | 2016-07-06 | — | — | CN | disclosed |
| CN-105732261-A | Selective hydrogenation method for trace acetylene in methanol-to-olefin device | 中国石油天然气股份有限公司 | 2016-07-06 | — | — | CN | disclosed |
| CN-105732286-A | Selective hydrogenation method of carbon three-fraction | 中国石油天然气股份有限公司 | 2016-07-06 | — | — | CN | disclosed |
| CN-105732274-A | Ethylene selective hydrogenation refining method | 中国石油天然气股份有限公司 | 2016-07-06 | — | — | CN | disclosed |
| US-20100270537-A1 | OPTOELECTRONIC DEVICES AND ORGANIC COMPOUNDS USED THEREIN | GENERAL ELECTRIC COMPANY (US) | 2010-10-28 | — | — | US | disclosed |
| EP-1076648-B1 | METHOD FOR THE CATALYTIC PRODUCTION OF SUBSTITUTED DIPYRIDYL DERIVATIVES | MERCK PATENT GMBH (DE) | 2006-07-12 | — | — | EP | disclosed |
| US-6500956-B1 | CONVERTING SUBSTITUTED HALOPYRIDINE DERIVATIVES WITH BASE AND REDUCING AGENT IN PRESENCE OF A PALLADIUM CATALYST | AXIVA GMBH (DE) | 2002-12-31 | — | — | US | disclosed |
| EP-1076648-A1 | METHOD FOR THE CATALYTIC PRODUCTION OF SUBSTITUTED DIPYRIDYL DERIVATIVES | Axiva GmbH (DE) | 2001-02-21 | — | — | EP | disclosed |
| WO-1999055675-A1 | METHOD FOR THE CATALYTIC PRODUCTION OF SUBSTITUTED DIPYRIDYL DERIVATIVES | AXIVA GMBH (DE) | 1999-11-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100270537-A1 | OPTOELECTRONIC DEVICES AND ORGANIC COMPOUNDS USED THEREIN | AOC3, C3AR1, AOC2 | MEN1 2141/4885NPC1 745/4885RAB9A 2097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.